三氧化二砷在肿瘤治疗中的应用  

Application of arsenic trioxide in the treatment of cancer

作　　者：姚红方[1,2] 张程[1] 张小润[1] 

机构地区：[1]贵州省人民医院呼吸与危重症医学科,550002 [2]贵阳遵义医学院,563000

出　　处：《中国医疗前沿》2013年第7期19-21,共3页China Healthcare Innovation

基　　金：贵州省科技基金[编号:黔科合J字(2005)2051号]

摘　　要：三氧化二砷是中药砒霜的主要成分,它被作为药物使用已经有2000多年的历史,最初的应用是治疗梅毒、肺结核等;从20世纪70年代在治疗复发性和难治性急性早幼粒细胞性白血病(APL)中取得较好疗效后,其药用价值开始受到了人们的关注,本世纪初,美国的FDA批准三氧化二砷用于治疗APL、多发性骨髓瘤(MM)、骨髓增生异常综合征(MDS)。自此国内外掀起了研究三氧化二砷的抗肿瘤作用及其机制的热潮,并进行了大量实验,本文就其在抗肿瘤方面的研究进展作一综述。Arsenic trioxid is a major component of the traditional Chinese medicine of arsenic, which was used as a drug has a history of over two thousand years, the initial application is the treatment of syphilis, tuberculosis and so on. From the nineteen seventies in the treatment of refractory and relapsed acute promyelocytic leukemia（APL） has good effect, Arsenic＇s medicinal value began to receive people＇s attention, At the beginning of this century, U.S. Food and Drug Administration allowed arsenic trioxide to acute promyelocytic leukemia, multiple myeloma and myelodysplastic syndrome.From then on, there was a stirring of interest in antitumor effection and mechanism of arsenic trioxid in domestic and foreign. And a number of experiments has been conducted arounding it.In this paper, the research progress in anti-tumor were reviewed.

关 键 词：三氧化二砷(As2O3) 肿瘤 

分 类 号：R730.5[医药卫生—肿瘤]